
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS‐CoV‐2 omicron variant: Could it be another threat?
Balamurugan Shanmugaraj, Ashwini Malla, Narach Khorattanakulchai, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1284-1288
Open Access | Times Cited: 31
Balamurugan Shanmugaraj, Ashwini Malla, Narach Khorattanakulchai, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1284-1288
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
The puzzling mutational landscape of the SARS‐2‐variant Omicron
Jacques Fantini, Nouara Yahi, Philippe Colson, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2019-2025
Open Access | Times Cited: 77
Jacques Fantini, Nouara Yahi, Philippe Colson, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2019-2025
Open Access | Times Cited: 77
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
SARS‐CoV‐2 Omicron and its current known unknowns: A narrative review
Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Nguyen Thi Hien Hau, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 41
Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Nguyen Thi Hien Hau, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 41
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Tracking and controlling the spatiotemporal spread of SARS-CoV-2 Omicron variant in South Africa
Chengzhuo Tong, Wenzhong Shi, Anshu Zhang, et al.
Travel Medicine and Infectious Disease (2021) Vol. 46, pp. 102252-102252
Open Access | Times Cited: 40
Chengzhuo Tong, Wenzhong Shi, Anshu Zhang, et al.
Travel Medicine and Infectious Disease (2021) Vol. 46, pp. 102252-102252
Open Access | Times Cited: 40
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, et al.
Vaccine (2022) Vol. 40, Iss. 32, pp. 4440-4452
Open Access | Times Cited: 31
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, et al.
Vaccine (2022) Vol. 40, Iss. 32, pp. 4440-4452
Open Access | Times Cited: 31
Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
Mohd Zulkifli Salleh, Mohd Nor Norazmi, Zakuan Zainy Deris
PeerJ (2022) Vol. 10, pp. e13083-e13083
Open Access | Times Cited: 29
Mohd Zulkifli Salleh, Mohd Nor Norazmi, Zakuan Zainy Deris
PeerJ (2022) Vol. 10, pp. e13083-e13083
Open Access | Times Cited: 29
The silent reservoir? SARS-CoV-2 detection in the middle ear effusion of patients with Otitis media with effusion after omicron infection
Chengzhou Han, Huifang Wang, Ying Wang, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 3, pp. 104229-104229
Closed Access | Times Cited: 5
Chengzhou Han, Huifang Wang, Ying Wang, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 3, pp. 104229-104229
Closed Access | Times Cited: 5
Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial
Suad Hannawi, Lixin Yan, Linda Saf Eldin, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102195-102195
Open Access | Times Cited: 14
Suad Hannawi, Lixin Yan, Linda Saf Eldin, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102195-102195
Open Access | Times Cited: 14
The spread of the omicron variant: Identification of knowledge gaps, virus diffusion modelling, and future research needs
Uttpal Anand, Tarun Pal, Alessandra Zanoletti, et al.
Environmental Research (2023) Vol. 225, pp. 115612-115612
Open Access | Times Cited: 12
Uttpal Anand, Tarun Pal, Alessandra Zanoletti, et al.
Environmental Research (2023) Vol. 225, pp. 115612-115612
Open Access | Times Cited: 12
Emergence of monkeypox
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Waranyoo Phoolcharoen
Asian Pacific Journal of Tropical Medicine (2022) Vol. 15, Iss. 5, pp. 193-195
Open Access | Times Cited: 21
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Waranyoo Phoolcharoen
Asian Pacific Journal of Tropical Medicine (2022) Vol. 15, Iss. 5, pp. 193-195
Open Access | Times Cited: 21
COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
Vo Van Giau, Eva Bagyinszky, Seong Soo A. An
Microorganisms (2022) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 18
Vo Van Giau, Eva Bagyinszky, Seong Soo A. An
Microorganisms (2022) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 18
COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2
Rohitas Deshmukh, Ranjit K. Harwansh, Akash Garg, et al.
Current Genomics (2024) Vol. 25, Iss. 2, pp. 69-87
Open Access | Times Cited: 3
Rohitas Deshmukh, Ranjit K. Harwansh, Akash Garg, et al.
Current Genomics (2024) Vol. 25, Iss. 2, pp. 69-87
Open Access | Times Cited: 3
Ever-evolving SARS-CoV-2: Latest variant KP.2 is on the rise
Balamurugan Shanmugaraj
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 6, pp. 241-242
Open Access | Times Cited: 3
Balamurugan Shanmugaraj
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 6, pp. 241-242
Open Access | Times Cited: 3
Pandemic COVID-19, an update of current status and new therapeutic strategies
Antonio Vitiello, Raffaele La Porta, Ugo Trama, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 10, pp. 1159-1165
Open Access | Times Cited: 17
Antonio Vitiello, Raffaele La Porta, Ugo Trama, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 10, pp. 1159-1165
Open Access | Times Cited: 17
Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern
Narach Khorattanakulchai, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4265-4276
Open Access | Times Cited: 16
Narach Khorattanakulchai, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4265-4276
Open Access | Times Cited: 16
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
In Silico Molecular Characterization of Human TMPRSS2 Protease Polymorphic Variants and Associated SARS-CoV-2 Susceptibility
Mohd Zulkifli Salleh, Zakuan Zainy Deris
Life (2022) Vol. 12, Iss. 2, pp. 231-231
Open Access | Times Cited: 9
Mohd Zulkifli Salleh, Zakuan Zainy Deris
Life (2022) Vol. 12, Iss. 2, pp. 231-231
Open Access | Times Cited: 9
An overview of Monkeypox Virus: Molecular Biology, Epidemiology, Pathogenesis, Treatment and Prevention Strategies
Nazim Hussain, Muhammad Hamza Ashraf, Rabia Arooj, et al.
(2024)
Open Access | Times Cited: 1
Nazim Hussain, Muhammad Hamza Ashraf, Rabia Arooj, et al.
(2024)
Open Access | Times Cited: 1
COVID‐19 in a common woolly monkey (Lagothrix lagothricha): First evidence of fatal outcome in a nonhuman primate after natural SARS‐CoV‐2 infection
Eduardo A. Díaz, Carolina Sáenz, Francisco Cabrera, et al.
American Journal of Primatology (2024) Vol. 86, Iss. 8
Closed Access | Times Cited: 1
Eduardo A. Díaz, Carolina Sáenz, Francisco Cabrera, et al.
American Journal of Primatology (2024) Vol. 86, Iss. 8
Closed Access | Times Cited: 1
Comprehensive mutation profiling from wastewater in southern Germany extends evidence of circulating SARS-CoV-2 diversity beyond mutations characteristic for Omicron
Shelesh Agrawal, Laura Orschler, Kira Zachmann, et al.
FEMS Microbes (2023) Vol. 4
Open Access | Times Cited: 3
Shelesh Agrawal, Laura Orschler, Kira Zachmann, et al.
FEMS Microbes (2023) Vol. 4
Open Access | Times Cited: 3
How serious is the Omicron variant? transmissibility, genomics, and responses to COVID-19 vaccines, and ‘Stealth’ Omicron variants
Yun Jung Choi, Krishna Prasad Acharya
Life Cycle (2022) Vol. 2
Open Access | Times Cited: 4
Yun Jung Choi, Krishna Prasad Acharya
Life Cycle (2022) Vol. 2
Open Access | Times Cited: 4
Emergence of SARS‐CoV‐2 variants KP.2 and KP.3 sparks concerns: What should we do?
Balamurugan Shanmugaraj
Health care science (2024) Vol. 3, Iss. 4, pp. 211-214
Open Access
Balamurugan Shanmugaraj
Health care science (2024) Vol. 3, Iss. 4, pp. 211-214
Open Access